Russell Investments Group Ltd. trimmed its position in CME Group Inc. (NASDAQ:CME - Free Report) by 5.5% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 850,014 shares of the financial services provider's stock after selling 49,925 shares during the quarter. Russell Investments Group Ltd. owned 0.24% of CME Group worth $225,245,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Prudential PLC grew its holdings in shares of CME Group by 1.5% during the 1st quarter. Prudential PLC now owns 19,218 shares of the financial services provider's stock worth $5,098,000 after purchasing an additional 277 shares in the last quarter. Resona Asset Management Co. Ltd. boosted its stake in CME Group by 7.5% in the first quarter. Resona Asset Management Co. Ltd. now owns 123,828 shares of the financial services provider's stock valued at $32,798,000 after buying an additional 8,685 shares in the last quarter. Rossmore Private Capital boosted its stake in CME Group by 3.5% in the first quarter. Rossmore Private Capital now owns 4,930 shares of the financial services provider's stock valued at $1,308,000 after buying an additional 166 shares in the last quarter. Trajan Wealth LLC boosted its stake in CME Group by 2.7% in the first quarter. Trajan Wealth LLC now owns 19,716 shares of the financial services provider's stock valued at $5,230,000 after buying an additional 519 shares in the last quarter. Finally, AIA Group Ltd boosted its stake in CME Group by 17.8% in the first quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider's stock valued at $4,416,000 after buying an additional 2,510 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several analysts recently weighed in on CME shares. Erste Group Bank lowered CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Piper Sandler increased their target price on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research report on Tuesday, July 15th. JPMorgan Chase & Co. dropped their target price on CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research report on Thursday, April 24th. Finally, Barclays set a $298.00 target price on CME Group and gave the company an "equal weight" rating in a research report on Thursday, July 24th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $261.93.
Check Out Our Latest Stock Analysis on CME
CME Group Trading Down 0.3%
Shares of CME traded down $0.78 during mid-day trading on Friday, reaching $273.92. 2,055,512 shares of the company were exchanged, compared to its average volume of 2,345,802. CME Group Inc. has a 52 week low of $204.16 and a 52 week high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market capitalization of $98.72 billion, a PE ratio of 26.52, a PEG ratio of 4.86 and a beta of 0.44. The business has a 50 day simple moving average of $275.53 and a two-hundred day simple moving average of $266.86.
CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%. The company had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period last year, the company earned $2.56 earnings per share. The firm's revenue was up 10.4% compared to the same quarter last year. On average, analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is 48.40%.
Insider Transactions at CME Group
In related news, Director William R. Shepard bought 256 shares of the business's stock in a transaction that occurred on Wednesday, June 25th. The shares were bought at an average price of $270.53 per share, with a total value of $69,255.68. Following the completion of the transaction, the director directly owned 258,196 shares in the company, valued at approximately $69,849,763.88. This represents a 0.10% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Charles P. Carey sold 500 shares of CME Group stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total value of $132,675.00. Following the transaction, the director directly owned 4,900 shares in the company, valued at approximately $1,300,215. The trade was a 9.26% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 2,450 shares of company stock valued at $676,663. Company insiders own 0.30% of the company's stock.
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
MarketBeat All Access